For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Amunix Pharmaceuticals, Inc

USPTO Granted Patents = 9

CIPO Patents = 4

EPO Patents = 3

Trademarks = 5

Forward Citations = 16

Loading Chart...

Loading Chart...

38 inventors (with patents filed for the assignee):

Volker Schellenberger (9 out of 66 patents)

Bee-Cheng Sim (4 out of 5 patents)

Fan Yang (3 out of 30 patents)

4. Joshua A Silverman (3 out of 56 patents)

5. Benjamin Spink (3 out of 15 patents)

6. Nathan C Geething (3 out of 20 patents)

7. Chia-wei Wang (3 out of 25 patents)

8. Desiree Thayer (3 out of 3 patents)

9. Chia-Wei Wang (3 out of 3 patents)

10. Jeffrey L Cleland (2 out of 47 patents)

11. Willem P Stemmer (2 out of 40 patents)

12. Wayne To (2 out of 18 patents)

13. Vladimir Podust (2 out of 10 patents)

14. Eric Johansen (2 out of 3 patents)

15. Darragh Maccann (2 out of 2 patents)

9 patents: Sort by Forward Citations

1. 12428494 - Compositions targeting prostate-specific membrane antigen and methods for making and using the same (2025-09-30),

2. 12215156 - HER-2 targeted bispecific compositions and methods for making and using the same (2025-02-04),

3. 12071456 - Extended recombinant polypeptides and compositions comprising same (2024-08-27),

4. 12060424 - Release segments and binding compositions comprising same (2024-08-13),

5. 11981744 - Chimeric polypeptide assembly and methods of making and using the same (2024-05-14),

6. 11713358 - Chimeric polypeptide assembly and methods of making and using the same (2023-08-01),

7. 10961287 - Extended recombinant polypeptides and compositions comprising same (2021-03-30),

8. 10953073 - XTEN conjugate compositions and methods of making same (2021-03-23),

9. 10870874 - Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same (2020-12-22),

Amunix Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving the lives of patients with its proprietary technology that enables the site-specific conjugation of therapeutics to proteins. The company is focused on developing novel therapies for cancer, autoimmune diseases, and other serious illnesses.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

9 Patents

#105 in South San Francisco, CA

#7,492 in California

#31,603 in US

South San Francisco, CA, United States of America

Amunix Pharmaceuticals, Inc

Forward Citations = 16

38 inventors:

Volker Schellenberger (9 out of 66 patents)

Bee-Cheng Sim (4 out of 5 patents)

Fan Yang (3 out of 30 patents)

4. Joshua A Silverman (3 out of 56 patents)

5. Benjamin Spink (3 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…